— Know what they know.
Not Investment Advice
Also trades as: AUP.TO (TSX) · $vol 4M

AUPH NASDAQ

Aurinia Pharmaceuticals Inc.
1W: -2.5% 1M: -5.9% 3M: +7.3% YTD: +0.7% 1Y: +86.1% 3Y: +51.3% 5Y: +29.6%
$15.22
-0.23 (-1.49%)
 
Weekly Expected Move ±6.0%
$13 $14 $15 $16 $17
NASDAQ · Healthcare · Biotechnology · Alpha Radar Neutral · Power 49 · $2.0B mcap · 126M float · 0.943% daily turnover · Short 49% of daily vol

📊 Key Metrics

TTM
$298M
Revenue
+20.6% YoY
$298M
Net Income
+648.4% YoY
$166M
Free Cash Flow
+158.7% YoY
91.6%
Gross Margin
53.3%
Op. Margin
44.2%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE62.2%
ROA45.8%
ROIC107.5%

Valuation

P/E6.8
P/B3.6
EV/EBITDA10.6

Leverage

Debt/Equity0.13
Current Ratio5.25
Interest Cov.16.5x

Quality Scores

Piotroski F8/9
Altman Z7.64
Beneish M8.45

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms